NEW YORK, September 3 /PRNewswire/ --

- New Business Unit Recently Launched First-Ever Multi-Touch Surface Computing Collaboration Solution for Telepresence

Teliris(R), (www.teliris.com) the leading provider of telepresence solutions since 1999, announced today the formal charter of the Teliris(R) Telepresence Research Labs as its newest business unit with the critical purpose of delivering the next-generation of immersive telepresence and immersive collaboration technologies.

MALVERN, England, September 3 /PRNewswire/ --

- Radical New Platform Designed From the Ground Up Delivers Intelligent Rheology Solutions

Malvern Instruments has today launched Kinexus, the radical new rotational rheometer platform whose development has been shaped by extensive market research and a fresh approach to addressing the real needs of users.

Designed entirely from the ground up, Kinexus redefines the rheometer. It enables users to spend less time learning how to interact with their system and more time investigating ways to characterize and enhance a material's performance.

LIVERPOOL, England, September 3 /PRNewswire/ --

- Attention: News, Industrial and Energy Correspondents

Unite members employed at Sellafield in Cumbria have voted overwhelming for industrial action in a dispute over pay.

88% of the workers have voted in favour of strike action after management failed to increase a pay offer of 2% on basic rates previously rejected by 90% of workers.

Unite is urging Sellafield management to improve the offer and get back around the table with trade unions in a final attempt to settle the dispute and avoid industrial action.

Unite Regional Officer Alan Westnedge, said: "We are extremely disappointed that the company are not prepared to move from a 2% offer on basic rates when inflation is at 5% and rising.

NAPA, California, September 3 /PRNewswire/ --

- AGENCY CHOSEN FOR LAUNCH OF PYRATINE-6(TM)

LONDON, September 3 /PRNewswire/ --

RTS Realtime Systems Group (RTS), a leading trading solutions provider, announced that the Kyte Group Limited (Kyte), a major UK-based clearing firm for derivatives and equities, has deployed RTS technology to offer direct market access (DMA) to European equities via the Merrill Lynch X-Direct trading platform.

Commented Peter Green, Kyte Group Chief Executive: "We are pleased to further build our relationship with RTS. By deploying its equities connectivity and trading tools, our clients can enjoy increased market reach for both outright trading and hedging."

Kyte's clients include proprietary trading firms, banks, hedge fund managers and market makers. The firm also offers institutional brokerage services.

CALGARY, Canada, September 3 /PRNewswire/ --

- Provides Shareholders With an Update on Strategic Review Activities

LINCOLN, Rhode Island, September 3 /PRNewswire/ --

SANTA FE, New Mexico, September 3 /PRNewswire/ --

- David Campbell Appointed as Director of European Sales

Strategic Analytics Inc., the leading provider of analytical and forecasting solutions for retail lenders, today announced that it has established Strategic Analytics Europe Ltd. The company also announced the appointment of David W. Campbell as Director of European Sales.

LUDWIGSHAFEN, Germany, September 3 /PRNewswire/ -- Hair isn't exactly lying still all the time. It's constantly in motion - we brush it, run our fingers through it, and style it in all kinds of tortuous ways. When we tax it and strain it, the shingles on the outside of a strand of hair can stand up - or even break off. But with the help of conditioner, the hair's protective outer layer is able to repair itself. In entertaining weekly episodes our Chemical Reporter answers questions of our Podcast listeners on Chemistry in our everyday life.

Direct subscription via RSS-Feed or iTunes (search for "basf"):

http://corporate.basf.com/en/podcast/reporter.xml

Podcast The Chemical Reporter, English edition:

http://www.basf.com/podcast

More podcasts:

SAN DIEGO, September 3 /PRNewswire/ --

Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company will present corporate updates at a number of upcoming industry and financial conferences. Nventa's presentations will focus on HspE7, the company's lead product candidate for the treatment of human papillomavirus (HPV)-related diseases, as well as the company's proprietary Toll-like Receptor 3 (TLR3) agonist vaccine adjuvant program and additional corporate developments.

Upcoming conferences at which the company will present include: